Aspirin use and melanoma: A UCLA pilot study

被引:4
作者
Famenini, Shannon [1 ]
Duan, Lewei [2 ]
Young, Lorraine [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
关键词
ACETYLSALICYLIC-ACID ASPIRIN;
D O I
10.1016/j.jaad.2015.03.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1094 / 1095
页数:3
相关论文
共 5 条
[1]   Aspirin use and melanoma risk: A review of the literature [J].
Famenini, Shannon ;
Young, Lorraine C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (01) :187-191
[2]  
Kuzbicki L, 2006, MELANOMA RES, V16, P29
[3]   Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice [J].
Vad, Nikhil M. ;
Kudugunti, Shashi K. ;
Wang, Hezhen ;
Bhat, G. Jayarama ;
Moridani, Majid Y. .
TUMOR BIOLOGY, 2014, 35 (05) :4967-4976
[4]   Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines [J].
Vad, Nikhil M. ;
Yount, Garret ;
Moridani, Majid Y. .
MELANOMA RESEARCH, 2008, 18 (06) :386-399
[5]   The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β [J].
Yin, MJ ;
Yamamoto, Y ;
Gaynor, RB .
NATURE, 1998, 396 (6706) :77-80